Krishna Institute of Medical Sciences Limited
Symbol: KIMS.BO
BSE
1965.3
INRMarkedspris i dag
47.3931
P/E-forhold
2.1584
PEG Ratio
157.28B
MRK Cap
- 0.00%
DIV Udbytte
Krishna Institute of Medical Sciences Limited (KIMS-BO) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1706.5 | 1899.9 | 2842.5 | ||||||||
balance-sheet.row.short-term-investments | 0 | 1090.4 | 1643.5 | 2321.2 | ||||||||
balance-sheet.row.net-receivables | 0 | 2718.9 | 1479.4 | 1373.8 | ||||||||
balance-sheet.row.inventory | 0 | 428.6 | 364.3 | 240.8 | ||||||||
balance-sheet.row.other-current-assets | 0 | 114.7 | 101.7 | 27.3 | ||||||||
balance-sheet.row.total-current-assets | 0 | 4776.4 | 3934 | 4511.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18575.1 | 9094.3 | 8308 | ||||||||
balance-sheet.row.goodwill | 0 | 3080.1 | 847.8 | 847.8 | ||||||||
balance-sheet.row.intangible-assets | 0 | 777.4 | 317.6 | 247.4 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3857.4 | 1165.3 | 1095.2 | ||||||||
balance-sheet.row.long-term-investments | 0 | 61.7 | 3338.1 | 192.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 401.9 | 32.1 | 29.4 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 1740.5 | 1509.6 | 224.8 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 24636.7 | 15139.5 | 9849.6 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.account-payables | 0 | 1742.5 | 1295.3 | 1318.7 | ||||||||
balance-sheet.row.short-term-debt | 0 | 445.8 | 302.1 | 884.3 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.7 | 87 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6335.9 | 2263.2 | 2279.4 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 12.4 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 606.7 | 417.5 | 442.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7068.7 | 2817 | 2816.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1449.6 | 955 | 459 | ||||||||
balance-sheet.row.total-liab | 0 | 10033.4 | 4967.1 | 5599.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 800.3 | 800.3 | 775.9 | ||||||||
balance-sheet.row.retained-earnings | 0 | 5382.8 | 2674.8 | -644.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 11140.6 | 11140.6 | 9224 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -628.4 | -742.6 | -718.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 16695.4 | 13873.1 | 8637.3 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.minority-interest | 0 | 2684.2 | 233.3 | 124.6 | ||||||||
balance-sheet.row.total-equity | 0 | 19379.6 | 14106.4 | 8762 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 566.9 | 3331.7 | 24.3 | ||||||||
balance-sheet.row.total-debt | 0 | 6781.7 | 2565.3 | 3163.7 | ||||||||
balance-sheet.row.net-debt | 0 | 6165.6 | 2308.9 | 2642.4 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -692.8 | -744.7 | 141.5 | ||||||||
cash-flows.row.account-receivables | 0 | -628.1 | -232.7 | 177.5 | ||||||||
cash-flows.row.inventory | 0 | 64.7 | -123.4 | 62.9 | ||||||||
cash-flows.row.account-payables | 0 | -410.8 | 101.2 | 239.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 281.4 | -489.7 | -338.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1128 | -1310.3 | -67.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.acquisitions-net | 0 | -2161.9 | -3240.9 | -352.7 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -5392.8 | -5828.1 | -2409.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 7010.4 | 6520 | 113.8 | ||||||||
cash-flows.row.other-investing-activites | 0 | 133.6 | 137 | 51 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -6155.9 | -4115.2 | -3541.8 | ||||||||
cash-flows.row.debt-repayment | 0 | -2410.8 | -2334.4 | -1300.4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1916.6 | 950.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 3294.2 | 1027.8 | 448.4 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 883.4 | 610 | 98.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1311.4 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 359.8 | -264.9 | 116.2 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 616.1 | 256.3 | 521.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 256.3 | 521.3 | 405.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 4320.9 | 3240.3 | 3559.7 | ||||||||
cash-flows.row.capital-expenditure | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.free-cash-flow | 0 | -1424.3 | 1537 | 2615.5 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 21976.8 | 16508.3 | 13122.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 8270.8 | 6170.6 | 4931.1 | ||||||||
income-statement-row.row.gross-profit | 0 | 13706 | 10337.6 | 8191 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.operating-expenses | 0 | 8958.4 | 5906.5 | 5063.8 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 17229.3 | 12077.1 | 9995 | ||||||||
income-statement-row.row.interest-income | 0 | 61.1 | 122.8 | 58 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 4887.5 | 4558.7 | 3134 | ||||||||
income-statement-row.row.income-before-tax | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 1190.9 | 1130.6 | 735.4 | ||||||||
income-statement-row.row.net-income | 0 | 3363.2 | 3326.8 | 2012.2 |
Ofte stillede spørgsmål
Hvad er Krishna Institute of Medical Sciences Limited (KIMS.BO) samlede aktiver?
Krishna Institute of Medical Sciences Limited (KIMS.BO) samlede aktiver er 29413030000.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er N/A.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 0.621.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er 42.228.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er 0.138.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er 0.209.
Hvad er Krishna Institute of Medical Sciences Limited (KIMS.BO) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er 3363220000.000.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 6781740000.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 8958440000.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 0.000.